BIRC5 and lung carcinoma: However, up to date, the BIRC5 -31C/G polymorphism was only reported to be associated with risks of lung cancer, [28] urothelial carcinoma, [31] sporadic colorectal cancer, [30] gastric cancer [32] and NPC in the present study.